GLP-1 Hair Loss: Why It Happens, How Long It Lasts, and What Actually Helps

Published Jan 15, 2025Updated Sep 30, 2026Last reviewed Jul 10, 2025

8 linked public sourcesEditorial, sourcing, and corrections policy

Hair shedding can occur during semaglutide or tirzepatide treatment. Rapid weight loss and reduced nutritional intake can trigger telogen effluvium, but a scalp assessment is needed to identify the type of hair loss. The practical response is to review the shedding pattern, recent weight and diet changes, and the medication plan together. [1]

Do not assume that every case is permanent, or that every case is explained entirely by weight loss. Current American Academy of Dermatology guidance identifies weight change and nutrition as likely contributors while also recognizing a possible direct drug effect. [1]

How common is hair loss in the trials?

The current product labels provide specific figures for the populations and doses studied:

Treatment and study group	Hair loss reported
Wegovy 2.4 mg injection, pooled adult weight-management trials	3.3%, compared with 1% on placebo [2]
Wegovy 7.2 mg injection trial	5.8% with 7.2 mg, 3.3% with 2.4 mg and 1% with placebo [2]
Zepbound pooled weight-management trials	5% with 5 mg, 4% with 10 mg and 5% with 15 mg, compared with 1% on placebo [3]

These are reports of hair loss, not a dermatologist-confirmed diagnosis of telogen effluvium in every participant. The Wegovy and Zepbound trial groups also differ, so their percentages are not a head-to-head comparison of which medicine is more likely to cause shedding.

Both labels describe the reported hair loss as associated with weight reduction. The Zepbound label reports more cases among women than men: 7.1% versus 0.5% in treated participants. [2,3]

Why shedding can start months after weight loss begins

Hair grows in cycles. A major change in health, marked weight loss or extreme dieting can move more follicles into the resting phase. The hairs then shed after a delay, often around three months after the trigger. This explains why the timing may not match the week you started treatment or increased the dose. [4]

Telogen effluvium usually causes shedding across the scalp. A widening part or gradual patterned thinning may indicate androgenetic hair loss, which can coexist with a shedding episode. A dermatologist distinguishes these by reviewing the history and examining the scalp. [4]

Write down when the shedding began, when your weight changed most quickly, and whether appetite or food variety fell sharply. The sequence is often more informative than the brand name alone.

How long does it last?

For typical telogen effluvium, the shedding phase usually lasts three to six months, with visible recovery of volume taking longer. Continued triggers can prolong the episode. This is a general hair-cycle pattern, not a guaranteed recovery date for every person taking a GLP-1 medicine. [4]

The AAD describes many people recovering their usual fullness within six to nine months after the body readjusts to a stressor. Persistent shedding, continued thinning or a different pattern calls for reassessment. You do not need to wait nine months before asking for help. [5]

What to do when you notice more hair in the shower

1. Identify the pattern

Take photographs of the part, temples and crown in the same lighting and at the same angle. Bring them to an appointment so the clinician can compare the change rather than relying on one day's shower drain.

Diffuse shedding after a period of weight loss fits a different pattern from patches, scalp inflammation or scaling. Those features deserve direct examination, particularly when the hair loss is progressing. A diagnosis helps determine whether nutritional correction, a hair treatment or both are appropriate. [1,6]

2. Review what you are actually eating

Reduced appetite can make it harder to meet nutritional needs. The 2025 joint advisory from nutrition and obesity societies emphasizes adequate nutrient intake and management of gastrointestinal symptoms during GLP-1 treatment. [7]

For a useful food record, note several typical days, including the foods you now avoid, portions you can finish and any meals regularly skipped because of nausea or fullness. Include protein sources such as eggs, yogurt, fish, poultry, tofu or beans that fit your preferences. A dietitian can translate that record into a practical plan. [7]

A protein target chosen for your overall nutrition plan is not a proven hair-regrowth dose. Increasing a supplement beyond that plan is not a substitute for identifying the cause of shedding.

3. Test for a suspected deficiency, rather than buying a supplement stack

A dermatologist may order blood tests when the history suggests iron deficiency, thyroid disease or another contributor. That is different from automatically checking ferritin, zinc and albumin every three months for everyone who starts treatment. [4,6]

Use supplements to address an identified need. The AAD's hair-loss treatment guidance recommends iron, zinc or biotin supplementation when testing shows a deficiency, rather than treating them as universal hair-growth products. [6]

High-dose biotin can interfere with laboratory tests, including certain troponin assays. Include the dose on your medicine list and tell the clinician or laboratory if you take it. [8]

4. Review dose tolerability with the prescriber

If nausea, constipation or early fullness is preventing adequate intake, discuss that before the next increase. The Wegovy instructions allow delayed escalation when a dose is not tolerated, and Zepbound maintenance-dose selection takes response and tolerability into account. Dose changes belong in that discussion; changing the schedule solely to treat hair loss has not been established as a regrowth treatment. [2,3]

Hair shedding alone does not automatically require stopping treatment. The decision should account for the hair diagnosis, nutritional intake, other side effects and the benefits of the medicine for the condition being treated. [1]

Does minoxidil help?

Minoxidil may be appropriate when an examination identifies pattern hair loss or another reason to use it. The AAD describes topical minoxidil as a treatment that can stimulate growth and help maintain density, with continued use needed to retain its benefits. [6]

Typical telogen effluvium often recovers as the trigger resolves. Starting minoxidil automatically at the first sign of shedding can obscure the more useful question: what type of hair loss is present, and what is driving it? [4,6]

What about the stomach symptoms occurring at the same time?

Nausea, constipation and belching can affect both comfort and food intake. A record of meal size, symptom timing and dose changes can help the prescribing team identify a manageable pattern. The nutrition advisory emphasizes adjusting food choices and portions around tolerability while maintaining nutritional quality. [7]

Severe abdominal pain, inability to keep fluids down, dehydration or constipation with rectal bleeding needs prompt clinical assessment. Those symptoms should be evaluated separately from the hair complaint. [2,3]

The medicines also retain their existing thyroid-tumor contraindications: Wegovy and Zepbound should not be used by people with a personal or family history of medullary thyroid carcinoma or MEN2. The labeling is based on rodent findings; whether these medicines cause those tumors in humans is unknown. [2,3]

What should you track before follow-up?

Keep the medication name and dose, dates of increases, weight trend, food record and scalp photographs together. Note whether shedding is slowing and whether short new hairs are appearing, rather than expecting full density to return immediately. That gives the prescribing clinician and dermatologist the information needed to coordinate the next step.

References

Evidence overview for GLP-1 Hair Loss: Why It Happens, How Long It Lasts, and What Actually Helps